Share with your friends

Legislative update: Ways and Means drug pricing bill, with tax provision

Ways and Means drug pricing bill, with tax provision

The House Ways and Means Committee on October 22, 2019, approved (by a vote of 24-17) H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act.


Related content

The bill includes an excise tax on selected drugs during periods in which the manufacturer is not in compliance with certain requirements of a proposed new drug price negotiation program.


  • Read a description of the bill prepared by the Joint Committee on Taxation: JCX-43-19

  • Read the Ways and Means Chairman’s statement and a statement from the ranking member in opposition to the bill

The KPMG logo and name are trademarks of KPMG International. KPMG International is a Swiss cooperative that serves as a coordinating entity for a network of independent member firms. KPMG International provides no audit or other client services. Such services are provided solely by member firms in their respective geographic areas. KPMG International and its member firms are legally distinct and separate entities. They are not and nothing contained herein shall be construed to place these entities in the relationship of parents, subsidiaries, agents, partners, or joint venturers. No member firm has any authority (actual, apparent, implied or otherwise) to obligate or bind KPMG International or any member firm in any manner whatsoever. The information contained in herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation. For more information, contact KPMG's Federal Tax Legislative and Regulatory Services Group at: + 1 202 533 4366, 1801 K Street NW, Washington, DC 20006.

Connect with us


Want to do business with KPMG?


loading image Request for proposal